|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 420.94 USD | +0.88% |
|
+2.80% | +14.11% |
| 11/03 | Elevance Health, Inc. Presents at Barclays 27th Annual Global Healthcare Conference 2025, Mar-11-2025 08:00 AM | |
| 11/03 | Elevance Health Expects FY Adjusted Earnings Of $34.15-$34.85 Per Share | RE |
| Capitalization | 9.57TCr 8.79TCr 8.46TCr 7.4TCr 14TCr 8,31800Cr 15TCr 97TCr 37TCr 3,50600Cr 36TCr 35TCr 14,22100Cr | P/E ratio 2025 * |
13.4x | P/E ratio 2026 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise value | 12TCr 11TCr 11TCr 9.26TCr 17TCr 10,41600Cr 19TCr 1,21300Cr 46TCr 4,39000Cr 45TCr 44TCr 17,80700Cr | EV / Sales 2025 * |
0.62x | EV / Sales 2026 * | 0.57x |
| Free-Float |
99.81% | Yield 2025 * |
1.62% | Yield 2026 * | 1.76% |
More valuation ratios
* Estimated data
More news
Last Transcript: Elevance Health, Inc.
More recommendations
More press releases
More news
| 1 day | +0.88% | ||
| 1 week | +2.80% | ||
| Current month | +6.06% | ||
| 1 month | +8.14% | ||
| 3 months | +10.36% | ||
| 6 months | -23.58% | ||
| Current year | +14.11% |
1 week
408.34
420.94
1 month
378
420.94
Current year
364.62
420.94
1 year
362.21
420.94
3 years
362.21
420.94
5 years
171.03
420.94
10 years
114.85
420.94
| Manager | Title | Age | Since |
|---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 64 | 20/11/2017 |
Mark Kaye
DFI | Director of Finance/CFO | 46 | 01/11/2023 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 54 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ramiro Peru
BRD | Director/Board Member | 69 | 30/11/2004 |
Robert Dixon
BRD | Director/Board Member | 69 | 01/07/2011 |
Lewis Hay
BRD | Director/Board Member | 69 | 01/07/2013 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.22% | 33 M€ | -5.28% | - | |
| 2.07% | 7 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.88% | +2.80% | -17.96% | -10.00% | 9.57TCr | ||
| +1.48% | -0.98% | -0.44% | -1.86% | 45TCr | ||
| +0.29% | -2.53% | -11.12% | +34.25% | 8.56TCr | ||
| +0.46% | -2.65% | -27.36% | -42.51% | 3.05TCr | ||
| +0.40% | -3.07% | -22.90% | -32.03% | 2.89TCr | ||
| -0.92% | -5.84% | -23.79% | -5.96% | 1.71TCr | ||
| +1.87% | +6.04% | +216.43% | +81.70% | 302.9Cr | ||
| +5.78% | +0.55% | +358.93% | +27.08% | 186.99Cr | ||
| +2.62% | -2.12% | -42.11% | -51.48% | 173.9Cr | ||
| +0.79% | -4.48% | -3.80% | - | 36Cr | ||
| Average | +1.36% | -1.23% | +42.59% | -0.09% | 7.12TCr | |
| Weighted average by Cap. | +1.13% | -0.90% | -4.94% | -1.36% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19TCr 18TCr 17TCr 15TCr 28TCr 16,67600Cr 30TCr 1,94100Cr 74TCr 7,02800Cr 72TCr 70TCr 28,50800Cr | 21TCr 19TCr 18TCr 16TCr 30TCr 17,86400Cr 32TCr 2,08000Cr 79TCr 7,52900Cr 77TCr 75TCr 30,53800Cr |
| Net income | 713.86Cr 655.87Cr 631.05Cr 551.88Cr 1.02TCr 62TCr 1.13TCr 7.22TCr 2.74TCr 26TCr 2.68TCr 2.62TCr 1,06100Cr | 813.48Cr 747.4Cr 719.12Cr 628.9Cr 1.17TCr 71TCr 1.28TCr 8.23TCr 3.12TCr 30TCr 3.05TCr 2.99TCr 1,20900Cr |
| Net Debt | 2.41TCr 2.22TCr 2.13TCr 1.87TCr 3.46TCr 2,09800Cr 3.81TCr 24TCr 9.26TCr 88TCr 9.04TCr 8.86TCr 3,58600Cr | 2.2TCr 2.02TCr 1.94TCr 1.7TCr 3.15TCr 1,91000Cr 3.47TCr 22TCr 8.43TCr 80TCr 8.23TCr 8.07TCr 3,26500Cr |
More financial data
* Estimated data
Employees
1,04,200
Sector
Managed Healthcare
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/25/14 | 420.94 $ | +0.88% | 14,51,690 |
| 13/25/13 | 417.25 $ | +1.51% | 17,53,382 |
| 12/25/12 | 411.04 $ | -2.61% | 21,35,391 |
| 11/25/11 | 422.04 $ | +3.05% | 31,53,892 |
| 10/25/10 | 409.55 $ | +0.02% | 21,39,548 |
Delayed Quote Nyse, March 15, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
420.94USD
Average target price
494.29USD
Spread / Average Target
+17.42%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ELV Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition